Skip to main content

Advertisement

SpringerLink
Log in

Care of the Elderly Patient on Oral Oncolytics for Advanced Disease

  • Hematology and Oncology (T Wildes, Section Editor)
  • Published:
Current Geriatrics Reports Aims and scope Submit manuscript

Abstract

Oral oncolytics are now a common component of cancer care for older individuals with advanced cancer when a new treatment regimen is needed. Many of the solid tumors in elderly patients may respond to the oral oncolytics, however, not without side effects and challenges to maintain adherence. This article describes some of the important areas to be considered when oral oncolytics are prescribed for elderly patients. A general overview of important intervention areas of focus is included.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013. National Cancer Institute. 2016. http://seer.cancer.gov/csr/1975_2013/ Accessed 25, 2016.

  2. Weingart SN, Li JW, Zhu J, et al. US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards. J Oncol Pract. 2012;8(1):7–12.

    Article  PubMed  Google Scholar 

  3. Gharwan H, Groninger H. Kinase inhibitors and monoclonal antibodies in oncology: clinical implications. Nat Rev Clin Oncol. 2016;13(4):209–27.

    Article  CAS  PubMed  Google Scholar 

  4. Molina-Garrido MJ, Mora-Rufete A, Guillen-Ponce C. Oral chemotherapy in elderly women with metastatic breast cancer. Anti-Cancer Agent Me. 2014;14(5):665–72.

    Article  CAS  Google Scholar 

  5. Halfdanarson TR, Jatoi A. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep. 2010;12(4):247–52.

    Article  CAS  PubMed  Google Scholar 

  6. Luciani A, Jacobsen PB, Extermann M, et al. The impact of fatigue and anemia on functional status in older cancer patients treated with chemotherapy. J Geriatr Oncol. 2012;3(3):182–8.

    Article  Google Scholar 

  7. Cohen HJ, Lan L, Archer L, Kornblith AB. Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803). J Geriatr Oncol. 2012;3(2):82–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hermosillo-Rodriguez J, Anaya DA, Sada Y, et al. The effect of age and comorbidity on patient-centered health outcomes in patients receiving adjuvant chemotherapy for colon cancer. J Geriatr Oncol. 2013;4(2):99–106.

    Article  PubMed  Google Scholar 

  9. Twelves C, Cortes J, Vahdat L, et al. Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies. Breast Cancer Res Tr. 2014;148(3):553–61.

    Article  CAS  Google Scholar 

  10. Prithviraj G, Koroukian S, Margevicius S, et al. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228–37.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Hurria A, Rosen C, Hudis C, et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc. 2006;54(6):925–31.

    Article  PubMed  Google Scholar 

  12. Stilley CS, Bender CM, Dunbar-Jacob J, Sereika S, Ryan CM. The impact of cognitive function on medication management: three studies. Health Psychol. 2010;29(1):50–5.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lange M, Rigal O, Clarisse B, et al. Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. Cancer Treat Rev. 2014;40(6):810–7. Specifically looking at cognitive dysfunction is important to cancer treatment in older cancer patients both in what treatment to use and how to manage the treatment. For the oral oncolytics, however, cognitive states are critical for adherence. Careful assessment is needed, and Lange and colleagues recommend a more sensitive screening test than the mini-mental status examination to make such an assessment.

    Article  PubMed  Google Scholar 

  14. Puts M, Tu H, Tourangeau A, et al. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Ann Oncol. 2014;25(3):564–77. Adherence with cancer treatment has not been examined much for older adults. Puts and colleagues have a systematic review to examine factors that influence adherence with cancer treatment in older adults with a special note to examine comorbidities and cognitive and sensor impairments that might affect adherence. This review found 22 manuscripts mostly with breast cancer and hormonal therapy. Factors associated with non-adherence varied widely. Little is known about the factors. More research is needed to investigate the adherence behavior of older adults, taking into account their multimorbidity.

    Article  CAS  PubMed  Google Scholar 

  15. Eton D, Elrayah T, Tost K, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Si P, Koo KN, Poon D, Chew L. Knowledge of prescription medications among cancer patients aged 65 and above. J Geriatr Oncol. 2012;3(2):120–30.

    Article  Google Scholar 

  17. Regnier Denois V, Pirson J, Nourissat A, et al. Adherence with oral chemotherapy: results from a qualitative study of the behavior and representations of patients and oncologists. Eur J Cancer Care. 2011;20(4):520–7.

    Article  CAS  Google Scholar 

  18. Egerton NJ. In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients. Am J Manag Care. 2016;22(4 Suppl):S99–103.

    PubMed  Google Scholar 

  19. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18(4):381–90.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crc Cr Rev Oncol-Hem. 2005;55(3):241–52.

    Article  Google Scholar 

  21. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Older Adult Oncology, version 1.2016. 2016 https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#senior. Accessed 11 Apr 2016.

  22. Corre R, Greillier L, Caer H, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small cell lung cancer: the phase iii randomized ESOGIA-GFPC-GECP 08-02 study. J Clin Oncol. 2016;34(13):1476–83.

    Article  PubMed  Google Scholar 

  23. Hurria A. Management of elderly patients with cancer. J Natl Compr Canc Netw. 2013;11(5.5):698–701.

    PubMed  Google Scholar 

  24. Mathes T, Antoine S, Pieper D, Eikermann M. Adherence enhancing interventions for oral anticancer agents: a systematic review. Cancer Treat Rev. 2014;40(1):102–8.

    Article  PubMed  Google Scholar 

  25. Holle L, Puri S, Clement J. Physician-pharmacist collaboration for oral chemotherapy monitoring: insights from an academic genitourinary oncology practice. J Oncol Pharm Pract. 2016;22(3):511–6.

    Article  PubMed  Google Scholar 

  26. Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32(24):2595–603. The international Society of Geriatric Oncology in 2005 made recommendations on geriatric assessments in older cancer patient. The panel recommended the following domains for inclusion in the GA: functional status, comorbidity, cognition, mental health status, fatigue, social status and support, nutrition, and presence of geriatric syndromes. They indicated that the GA can be used to predict complications and overall survival and impact of GA findings to make treatment decisions. The utility of geriatric assessment in oncology practice is important.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Thompson K, Dale W. How do I best manage the care of older patients with cancer with multimorbidity? J Geriatr Oncol. 2015;6(4):249–53. Since for most older adult, cancer patients have several other chronic conditions. Thompson speaks to the concept of multimorbidity in which overlapping chronic conditions are managed as equally important to patient quality of life and outcomes. Clinicians need practical guidance for the rational approach to these patients, and these authors recommend the American Geriatrics Society’s Guiding Principles as a point of clinical decision making and management. Guiding principles include patient preferences and evidence-based interventions, estimating prognosis, considering treatment feasibility, and optimizing therapy and treatment plans as they apply to cancer.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, College of Human Medicine, Michigan State University, 135 East Fee Hall, East Lansing, MI, 48824, USA

    Charles W. Given

  2. College of Nursing, Michigan State University, C383 Bott Building, East Lansing, MI, 48824, USA

    Barbara A. Given

Authors
  1. Charles W. Given
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara A. Given
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles W. Given.

Ethics declarations

Conflict of Interest

Charles Given and Barbara Given report grants from NIH/NCI, from null, during the conduct of the study.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Hematology and Oncology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Given, C.W., Given, B.A. Care of the Elderly Patient on Oral Oncolytics for Advanced Disease. Curr Geri Rep 5, 233–239 (2016). https://doi.org/10.1007/s13670-016-0183-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13670-016-0183-8

Keywords

Search

Navigation